Old Web
English
Sign In
Acemap
>
authorDetail
>
Deendyal Bhurta
Deendyal Bhurta
Council of Scientific and Industrial Research
Biology
In vivo
Cyclin-dependent kinase
Clinical trial
Computational biology
4
Papers
5
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Analyzing the scaffold diversity of cyclin-dependent kinase inhibitors and revisiting the clinical and preclinical pipeline.
2021
Medicinal Research Reviews
Deendyal Bhurta
Sandip B. Bharate
Show All
Source
Cite
Save
Citations (0)
A rohitukine derivative IIIM-290 induces p53 dependent mitochondrial apoptosis in acute lymphoblastic leukemia cells.
2021
Molecular Carcinogenesis
Mubashir J. Mintoo
Sameer U. Khan
Abubakar Wani
Sumera Banu Malik
Deendyal Bhurta
Sandip B. Bharate
Fayaz Malik
Dilip M. Mondhe
Show All
Source
Cite
Save
Citations (1)
Evaluation of rohitukine-enriched fraction of Dysoxylum binectariferum Hook.f. (leaves) as anti-arthritic phytopharmaceutical candidate: Chemical standardization, in-vivo validation, formulation development and oral pharmacokinetics
2020
Journal of Ethnopharmacology
Vikas Kumar
Sonali S. Bharate
Deendyal Bhurta
Mehak Gupta
Sumit G. Gandhi
Deepika Singh
Sundeep Jaglan
Ajay Kumar
Ram A. Vishwakarma
Sandip B. Bharate
Show All
Source
Cite
Save
Citations (2)
Impurity profiling of anticancer preclinical candidate, IIIM-290
2019
Journal of Pharmaceutical and Biomedical Analysis
Vikas Kumar
Deendyal Bhurta
Ankita Sharma
Puneet Kumar
Sandip B. Bharate
Ram A. Vishwakarma
Sonali S. Bharate
Show All
Source
Cite
Save
Citations (2)
1